We strongly advise you to harness Intec Pharma fundamental analysis to see if markets are presently mispricing the organization. In other words this interface allows you to validate available fundamentals of Intec Pharma as well as the relationship between them. . We found seventeen available reported financial drivers for Intec Pharma which can be compared to its competitors. Use Intec Pharma Ltd Current Ratio, Cash Flow from Operations, Number of Employees, as well as the relationship between Book Value Per Share and Earnings Per Share to make sure your decision on pricing Intec Pharma is adequate. Use Intec Pharma to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Intec Pharma to be traded at 1569.75 in 30 days.
Intec Pharma Company Summary
Intec Pharma competes with Elbit Systems, Electra Ltd, and Clal Insurance. Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel. Intec Pharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 70 people.
Intec Pharma Return On Asset vs Cash Flow from Operations
Intec Pharma Ltd is regarded fourth in return on asset category among related companies. It is regarded fourth in cash flow from operations category among related companies .
|Return On Asset ( % )|
|Cash Flow from Operations|
Intec Pharma Market Fundamentals